DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FELODIPINE

« Back to Dashboard

Clinical Trials for Felodipine

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00367939	Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine	Completed	Novartis	Phase 3	The purpose of this study is to evaluate the efficacy of valsartan plus amlodipine in hypertensive patients not responding to treatment with ACE inhibitor plus calcium channel blocker
NCT00392262	A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients	Completed	Novartis	Phase 3	The purpose of this study is to evaluate the efficacy of valsartan plus amlodipine in hypertensive patients not responding to treatment with amlodipine or felodipine alone.
NCT00507845	Use of Ramipril and Felodipine Combination Therapy in Hypertension: An Effectiveness Study With Local Patients in Argentina	Completed	Sanofi	Phase 4	Primary: - To assess effectiveness of Ramipril-Felodipine in hypertensive Argentinean patients Secondary: - To assess tolerability of Ramipril-Felodipine in hypertensive Argentinean patients.
NCT00841880	China Medical University Hospital (CMUH) Triapin Listing	Completed	Sanofi	Phase 4	The objective of this study is to compare the reduction in office seated systolic blood pressure (BP) following a 8 weeks regimen of ramipril 5mg plus felodipine 5mg versus ramipril 10mg. To compare the response rate (defined as office systolic blood pressure (SBP) / Diastolic blood pressure (DBP) reduce more than 10mmHg from baseline), and BP controlled rate (defined as SBP<140mmHg and/or DBP<90mmHg) and as SBP < 130 mmHg and /or DBP < 80 mmHg in diabetes,chronic kidney disease, known Coronary Arterial Disease (CAD) or CAD equivalent, or 10-year Framingham risk score > 10%. To ascertain the safety and tolerability of ramipril/felodipine versus ramipril in Taiwanese population. To compare compliance with fixed dose combination of ramipril/felodipine versus ramipril treatment.
NCT00905333	Evaluation of the Pharmacokinetic Interaction Between Candesartan and Felodipine After Ingestion of a Specific Meal	Completed	Clínica São Lucas, Hospital Sírio Libanês de Itatiba S/C	Phase 1	The purpose of this study is to evaluate the pharmacokinetic interaction of test formulations of candesartan and felodipine in a combination package comparing with the fasting intake of commercial formulations of both Atacand ® and Splendil®

Clinical Trial Conditions for Felodipine

Condition Name

Condition Name for Felodipine
Intervention	Trials
Hypertension	8
Healthy	5
Sexual Dysfunction	1
Food-Drug Interactions	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Felodipine
Intervention	Trials
Hypertension	7

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Felodipine

Trials by Country

Trials by Country for Felodipine
Location	Trials
China	3
Brazil	2
Germany	2
India	2
Argentina	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Felodipine

Clinical Trial Phase

Clinical Trial Phase for Felodipine
Clinical Trial Phase	Trials
Phase 4	5
Phase 3	2
Phase 1	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Felodipine
Clinical Trial Phase	Trials
Completed	14
Unknown status	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Felodipine

Sponsor Name

Sponsor Name for Felodipine
Sponsor	Trials
Ranbaxy Laboratories Limited	2
AstraZeneca	2
Torrent Pharmaceuticals Limited	2

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Felodipine
Sponsor	Trials
Other	12
Industry	11

Export unavailable in trial.
Subscribe for complete access.